Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
64K SF Boulder Lab Leased To Pharma Company: The Denver Deal Sheet
CordenPharma Colorado has signed a 15‑year lease for a 64,000 SF purpose‑built lab in Boulder’s Flatiron Park, expanding its peptide development capabilities adjacent to an existing manufacturing plant. The speculative building, completed in 2024, features adaptable lab grids, advanced utilities and specialized waste disposal. Flatiron Park, owned by BioMed Realty, comprises 24 buildings and over 1 million SF of R&D and office space across 15 acres. The lease highlights Boulder’s rising profile as a biotech hub within Colorado’s competitive commercial‑real‑estate market.
Best in KLAS 2026: Executive Insights for Strategic Healthcare Technology Investment
Best in KLAS 2026 delivers a data‑driven analysis of healthcare technology solutions, ranking platforms by performance ratings, measurable outcomes, and innovation trajectories. It aggregates validated customer feedback and market performance data to help executives de‑risk technology investments. The report highlights...
Reshaping Leukemia Treatment and QOL Through Improved PROM Data Integration
A recent Hematology Reports review examined 15 randomized trials that integrated patient‑reported outcome measures (PROMs) into leukemia research. The analysis found that PROMs such as EORTC QLQ‑C30 and EQ‑5D not only captured quality‑of‑life domains but also independently predicted overall survival...
Scale Ambient AI with Strategic Partnerships
Healthcare technology firms are increasingly embedding Ambient Clinical Intelligence (ACI) into EHR, telehealth, and care‑management platforms to cut administrative load and speed revenue cycles. Building ACI models internally demands extensive engineering resources, prompting many vendors to seek external expertise. Suki’s...
Report: 5 AI Agent Trends to Watch in Healthcare & Life Sciences
Google Cloud’s 2026 report spotlights five AI‑agent trends reshaping healthcare and life sciences, from automating clinical paperwork to accelerating drug discovery. The analysis stresses that unlocking AI value requires leaders to discard legacy mindsets and foster a culture that embraces...
GDUFA Type II API DMF Payment Receipts Report
The FDA’s GDUFA Type II API DMF payment report shows 385 payments in FY 2023, a dip to 264 in FY 2024, a rebound to 374 in FY 2025, and 90 early‑year payments in FY 2026. Monthly counts reveal a pronounced September 2023 spike of 103...
Fiscal Year 2026 Generic Drug Science and Research Initiatives Public Workshop - 06/08/2026
The FDA is holding its Fiscal Year 2026 Generic Drug Science and Research Initiatives public workshop on June 8‑9, offering both in‑person and virtual attendance. The two‑day event will review current research gaps and solicit stakeholder input to shape the FY 2027...
Scientists Laud Potentially Life-Changing Drug for Children with Resistant Form of Epilepsy
Preliminary trials of Zorevunersen, an experimental therapy for Dravet syndrome, showed it is safe and well tolerated in 81 children. A single 70 mg dose reduced seizures by about 50%, and three doses cut seizures roughly 80% compared with baseline. The...
Proscia Earns Top Score in KLAS Digital Pathology Report
Proscia topped the KLAS Research Digital Pathology 2026 report with a 95.2 overall performance score, the highest among U.S. vendors. The company earned A+ and A grades across six customer‑experience categories, and every surveyed client said they plan to keep...
The Health System Opportunity Stack: A Builder’s Guide to the Most Underserved Enterprise in America
Health systems are drowning in operational blind spots, especially in financial operations, while existing software focuses on clinical documentation. The essay maps a high‑value opportunity stack—from payer‑contract intelligence and AP automation to workforce forecasting, OR utilization, and prior‑authorization automation—highlighting quantifiable...
AI-Enabled Lesion Quantification Tool Earns New CPT Code
The American Medical Association has granted a Category 3 CPT code (X567T) to AIQ Solutions’ TRAQinform IQ, an AI‑enabled lesion quantification platform cleared by the FDA in 2018. The tool analyzes changes in lesion size and metabolic activity, providing clinicians with more...
Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought
A pooled analysis of the MOMENTUM 3 and ARIES‑HM3 trials involving 1,983 HeartMate 3 LVAD recipients identified an optimal early mean arterial pressure (MAP) of 85‑100 mm Hg, with 85‑95 mm Hg appearing ideal. Patients who spent more time within this range during the first 90...
Nuance Audio Glasses Help Understand Speech in Noisy Settings
A study published in the Journal of Otolaryngology‑ENT Research found that Nuance Audio Glasses, an over‑the‑counter hearing solution from EssilorLuxottica, improve speech‑reception thresholds by an average of 3.48 dB in noisy environments. Twenty adults with mild‑to‑moderate hearing loss achieved 50 % word...
CDC Finds Maternal Mortality Rate Dropped in 2024
The CDC reports that the U.S. maternal mortality rate fell to 17.9 deaths per 100,000 live births in 2024, a figure statistically indistinguishable from the 18.6 recorded in 2023. Black women experienced a mortality rate of 44.8 per 100,000, far...
Deadline March 31 to Apply for AHA Next Gen Fellowship
The American Hospital Association (AHA) announced that the application deadline for its Next Gen fellowship is March 31. The program targets emerging healthcare leaders, offering mentorship, networking, and strategic projects across member hospitals. Applicants must submit a brief proposal outlining a health‑system...
AHA Podcast: Advancing Community Health
The American Hospital Association released a multi‑segment podcast highlighting how hospitals are expanding beyond clinical walls to address social determinants of health. Leaders from Manatt Health, CommonSpirit Health, Inova Health System, and Owensboro Health discuss initiatives tackling food insecurity, workforce...
Endothelin Receptor Antagonist REMS Information
The FDA has eliminated risk evaluation and mitigation strategy (REMS) requirements for embryofetal toxicity (EFT) across all endothelin receptor antagonist (ERA) medicines, concluding that labeling alone sufficiently communicates the risk. The change, effective April 2025, applies to ambrisentan, macitentan‑containing products, and...
New AI-Enabled Heart Failure Implant Shows Early Potential
Relief Cardiovascular unveiled its AI‑enabled Relief System, an implantable valve and sensor that modulates inferior vena cava pressure to boost renal perfusion in diuretic‑resistant heart‑failure patients. In the first‑in‑human RELIEF‑FIH study of eight European participants, the device achieved 100% procedural...
AI and Technology Alone Won't Fix Revenue Cycle Challenges: The Automation Paradox in RCM
Healthcare finance leaders are pouring capital into AI and automation to solve revenue cycle management (RCM) challenges, yet many are discovering that automating flawed workflows only accelerates errors. The emerging "automation paradox" shows that without clean data and standardized processes,...
Drug Trials Snapshots: MYQORZO
MYQORZO (aficamten), a cardiac myosin inhibitor, received FDA approval on Dec 19 2025 for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Approval is based on the SEQUOIA‑HCM phase III trial, a randomized, double‑blind, placebo‑controlled study of 282 patients across 14 countries. At 24 weeks,...
Medicaid Expansion Linked to Lower Breast Cancer Deaths, but Disparities Persist
A recent JAMA Network Open study of over 1.5 million women shows Medicaid expansion under the ACA lowered breast cancer mortality by 4.8% compared with non‑expansion states. Hispanic patients experienced the largest relative gain—a 19% hazard reduction—while Black women saw modest...
FactChecking Claims in Casey Means’ Surgeon General Confirmation Hearing
During her March 2026 Senate confirmation, Dr. Casey Means faced intense questioning on vaccine policy, her professional credentials, and potential conflicts of interest. FactCheck.org examined the back‑and‑forth, verifying that her statements on vaccine safety aligned with CDC data and that...
HID Debuts Cloud‑based Visitor Verification System for Healthcare
HID Global unveiled a cloud‑based visitor verification platform at HIMSS 2026, designed for hospitals to authenticate and track visitors in real time. The solution integrates directly with major electronic health record systems such as Epic and Oracle Health, enabling photo capture,...
Talking Health Care Costs in Youngstown
Democratic lieutenant‑governor candidate David Pepper condemned Republican gubernatorial frontrunner Vivek Ramaswamy’s claim that Medicare and Medicaid are "mistakes" during a Youngstown news conference. Pepper highlighted that over 2.5 million Ohioans depend on Medicare and more than 3 million on Medicaid, arguing that...
Orai1 Switches Ca2+ Signals, Balances Erythropoiesis
Researchers have identified the Orai1 calcium channel as a pivotal regulator of intracellular Ca2+ signals that govern erythropoiesis. Genetic ablation of Orai1 in mouse models leads to impaired red‑cell maturation and anemia, while pharmacologic activation rescues normal blood counts. The...
A Fair Amount of ARPA-H Funding Is Being Used for Clinical Trials Relevant to Aging
ARPA‑H is committing up to $144 million to healthspan‑focused human trials through its PROSPR program, funding seven teams to develop early biomarkers and surrogate endpoints for aging interventions. The agency has awarded Cambrian Bio $30.8 million for an oral rapamycin analog targeting...
New C-Suite Hospice, Palliative Care Executives Step Forward
Hospice and palliative‑care providers announced several C‑suite moves, including Mettle Health’s new Chief Growth Officer, Camille Borgo, to broaden service reach. Legacy Hospice named Elaine Ziegler as CEO after Clark Blair’s departure, while Island Hospice appointed Patricia Pancner as its new chief executive....
Photobiomodulation: Revolutionary Breakthrough or Scam?
The Valeda photobiomodulation system received FDA authorization in November 2024 and has been used clinically since summer 2025 to treat retinal aging. A modest 148‑eye, two‑year study showed statistically significant gains in best‑corrected visual acuity and a lower rate of progression to...
Canadian Pediatric Journal Admits 100+ Fabricated Case Reports
This is probably just the surface and it goes much deeper. The official journal of the Canadian Paediatric Society has just acknowledged that more than 100 of its case reports are fabricated. Incredible reporting from @RetractionWatch: https://retractionwatch.com/2026/03/03/canadian-pediatric-society-journal-correction-case-reports-fictional-paediatrics-child-health/
Cell‑free DNA Test Predicts Liver Disease and Mortality
We've used a blood test—cell free DNA—for detecting cancer or prenatal fetal abnormalities. It turns out it can be used to detect liver diseases and all-cause mortality from other conditions @ScienceTM https://t.co/IJxPMq7hGU
Syantra’s Breast Cancer Blood Test Isn’t Looking for Cancer at All
Syantra, a Calgary‑based biotech, is preparing to launch Onco‑ID, a breast‑cancer blood test that detects the body’s immune response rather than circulating tumor DNA. Using machine‑learning analysis of gene‑expression biomarkers, the test aims to identify cancer earlier than mammography and...
Uniform Consent Language Needed for Scalable Health Data Interoperability
When every state regulates consent differently, scale breaks. Mariann Yeager shares why model language and technical standards are critical for nationwide interoperability. 👇 https://t.co/Aa3zjJYTw4 @sequoiaproject #patientadvocates #HITSM https://t.co/I3cN0lmdLk
FDA COO Butler Retires After One Year; Deputy Assumes Role
after just one year in the position, FDA COO Butler will retire, and his deputy will take over in April - https://t.co/9qmmIiuWX2
Oncolytic Virotherapies in Ovarian Cancer and NSCLC with Genelux CEO Thomas Zindrick — Episode 245
Genelux Corporation’s President and CEO Thomas Zindrick discussed the company’s oncolytic virotherapy programs targeting ovarian cancer and non‑small cell lung cancer on the Xtalks Life Science Podcast. The interview highlighted the therapeutic potential of engineered viruses to stimulate anti‑tumor immunity...
American Health Care Policy Reform: Why We Need a Bipartisan Commission
The United States is confronting a health‑care affordability crisis, with one‑third of citizens postponing care and 41 percent burdened by medical debt. Federal spending reached $5.3 trillion in 2024—about 18 % of GDP—and is projected to climb to $8.6 trillion by 2033. Public polls...
FDA Grants 510(k) Clearance for Expanded Capabilities of MR Injection System
The U.S. Food and Drug Administration granted Bayer 510(k) clearance for its MEDRAD MRXperion injector, extending the device’s approved magnetic field compatibility to include 7‑Tesla MRI scanners. The clearance also adds Imaging Scanner Interface 2 (ISI2), enabling direct communication between...
All Family Weekly Health Briefing
The FDA is reportedly reconsidering its stance on peptide compounds, a shift potentially driven by officials linked to Robert F. Kennedy Jr., which could broaden research and bio‑hacking applications. Meanwhile, ivermectin has re‑entered public discourse after high‑profile media mentions, prompting...
CMS Launches Effort to Unify Medicare Claims Processing Systems
The Centers for Medicare & Medicaid Services (CMS) has opened a competitive window for an eight‑year contract to deliver a unified, commercial‑off‑the‑shelf software platform called ClaimsCore. The system must consolidate four legacy claim‑processing applications, support over 2 million active users and...
Over-The-Counter Monograph Drug User Fee Program (OMUFA)
The FDA’s Over‑The‑Counter Monograph Drug User Fee Program (OMUFA) will assess an annual facility fee of $36.467 million for FY 2025, payable by June 2, 2025. All owners of OTC monograph drug facilities, including contract manufacturing organizations (CMOs), are subject to the fee, with...
Blackstone Invests $400M in Teva, Sanofi Gut Drug
Blackstone puts $400M into Teva, Sanofi gut disease drug https://t.co/CkxPaI6CPr @ByJonGardner $TEVA $SNY $MRK $RHHBY
Rebuilding Patient Trust Through the Evolutionary Mismatch Framework
Board‑certified emergency physician Vikas Patel proposes the evolutionary mismatch framework to rebuild patient trust. He argues that modern chronic diseases stem from a gap between ancient human biology and today’s lifestyle, not from a broken body. By reframing illness as...
Behind the Curve
The rapid rise of generative AI is outpacing medical education in Canada, leaving most students without formal AI training. A 2022 survey found 85% of Canadian medical students reported no AI curriculum, while recent initiatives at schools such as U...
AI Predicts 5‑year Health Risks From Routine CT Scans
When your "normal" abdominal CT tells you about the 5-year future risks that can't be seen by radiologists, but can by AI (Merlin) https://t.co/DemC983uKz https://t.co/9jqZyVTD3p
CTMX Soars 660% Ahead of Masked ADC Catalyst
$CTMX, +660% in 12 months, approaches its masked ADC catalyst. Via @ApexOnco -> https://t.co/oQI1iQiV4N ( $JANX -58% in the same timeframe)
Glaucoma Coaching Program Improved Medication Adherence
A randomized trial of the Support, Educate, Empower (SEE) glaucoma coaching program showed a significant rise in medication adherence and a reduction in glaucoma‑related distress compared with mailed education. Six‑month electronic adherence averaged 77.6% in the coached group versus 58.0%...
UnityAI Secures $8.5M to Scale Agentic AI for Healthcare Operations
UnityAI announced an $8.5 million Series A round led by Third Prime, bringing its total capital to $15 million. The startup deploys an agentic AI workforce that autonomously manages patient scheduling, referrals, and staff shift coordination across hundreds of care sites. It already...
Evo 2 Open‑Source Tool Predicts Non‑Coding Pathogenicity
It got me at "across all domains of life" Predicting pathogenicity of non-coding regions, produces sequences at genome scale, and much more Evo 2, open-source, @Nature today @arcinstitute @pdhsu @BrianHie https://t.co/9CZWmPFhjd
Autism Research Leaders Launch Independent Committee to Counter RFK’s Panel
Leading autism researchers and advocates have launched the Independent Autism Coordinating Committee (I‑ACC) to provide a science‑centered counterweight to the federal Interagency Autism Coordinating Committee (IACC) reshaped by HHS Secretary Robert F. Kennedy Jr. The federal IACC guides roughly $2 billion in annual autism...
Magentus Launches UK Advisory Board to Strengthen Clinical Diagnostics Strategy
Magentus announced the creation of a UK Advisory Board composed of senior NHS figures such as Dame Barbara Hakin and Professors Ian Abbs and Erika Denton. The board will provide independent insight to shape product direction, align with NHS priorities...
Systemic Failure in Professional Environments: The Myth of Protection
The article argues that professional environments mistakenly equate contribution, credentials, and service with safety, exposing a systemic failure that spans health care, academia, law enforcement and corporate sectors. It uses the tragic case of Alex Pretti to illustrate how conditional...